Curtiss-Wright Total Cost of Revenue decreased by 1.6% to $582.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.5%, from $513.18M to $582.20M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 8.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $396.78M | $383.61M | $405.27M | $358.06M | $380.84M | $398.33M | $465.18M | $409.45M | $444.82M | $442.86M | $481.06M | $459.41M | $500.69M | $500.66M | $506.88M | $513.18M | $550.42M | $541.70M | $591.54M | $582.20M |
| QoQ Change | — | -3.3% | +5.6% | -11.6% | +6.4% | +4.6% | +16.8% | -12.0% | +8.6% | -0.4% | +8.6% | -4.5% | +9.0% | -0.0% | +1.2% | +1.2% | +7.3% | -1.6% | +9.2% | -1.6% |
| YoY Change | — | — | — | — | -4.0% | +3.8% | +14.8% | +14.4% | +16.8% | +11.2% | +3.4% | +12.2% | +12.6% | +13.1% | +5.4% | +11.7% | +9.9% | +8.2% | +16.7% | +13.5% |